期刊文献+

糖肾安对糖尿病肾病炎症因子影响的临床研究 被引量:25

Clinical Influence of Tangshenan Prescription on Inflammation Factors in Diabetic Nephropathy
原文传递
导出
摘要 目的:观察益气养阴、祛瘀生新复方(糖肾安)对糖尿病肾病(DN)炎症因子的影响。方法:将45例DN患者随机分为治疗组30例,对照组15例,两组均予西医常规治疗,治疗组在此基础上配合糖肾安治疗,疗程均为8周。观察患者临床疗效及空腹血糖(FBG)、血清总胆固醇(TC)、甘油三脂(TG)、炎症因子超敏C反应蛋白(hs-CRP)、肿瘤坏死因子(TNF-α)、白细胞介素-6(IL-6)的变化。结果:治疗后总有效率治疗组为86.7%,对照组为53.3%,两组比较差异显著(P<0.05)。两组治疗后FBG,TC,TG均较治疗前明显下降(P<0.05,P<0.01);治疗组TC,TG下降优于对照组(P<0.05)。治疗后治疗组Hs-CRP,IL-6,TNF-α较治疗前显著下降(P<0.05,P<0.01),且治疗组下降明显优于对照组(P<0.05,P<0.01)。治疗后对照组Hs-CRP水平亦较治疗前明显下降(P<0.01),但IL-6,TNF-α改善不明显。结论:在西药治疗的基础上加用糖肾安,可提高DN的临床疗效,改善血脂代谢,下调相关炎症因子水平。 Objective: To observe the clinical influence of Tangshenan, a compound prescription of supplementing qi and nourishing yin and dispelling stasis to promote regeneration, on inflammation factors in diabetic nephropathy (DN). Method: . Forty-five DN patients were divided into treatment group ( n = 30) and control group (n = 15) at random. And each of the two groups was treated with western medicine routinely, and the treatment group was combined with Tangshenan on this basis of western medicine. The two groups were both for a treatment course of 8 weeks. Then the variations of patients' clinical responses, fasting blood glucose (FBG) , serum total cholesterol (TC) , Triglyceride (TG) , the inflammation factors of high-sensitivity c-reactive protein ( hs-CRP), tumor necrosis factor (TNF-α) and interleukin-6 (IL-6), were investigated. Result: After treatment, the total effectiveness of treatment group was 86.7% , and the control group was 53.3% , with significant difference (P 〈0.05). For both the two teams, FBG, TC and TG were decreased significantly (P 〈0.05, P 〈0.01 ) after treatment. And the treatment group' s TC and TG' s decreasement was better than that in the control group. The treatment group' s Hs-CRP, IL-6 and TNF-α were decreased significantly (P 〈0.05, P 〈0.01 ) after treatment. The control group' s Hs-CRP level was also decreased significantly (P 〈 0.01 ) after treatment, but the improvement of IL-6 and TNF-α were not obvious. Conclusion: On the basis of western medicine, if combined with Tangshenan, the curative effect can be improved, the blood lipid metabolism can be improved, and the regularinflammation factors can be down-regulated.
机构地区 广州中医药大学
出处 《中国实验方剂学杂志》 CAS 北大核心 2012年第16期320-323,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 广东省中医药局课题(2060071)
关键词 糖尿病肾病 糖肾安 HS-CRP TNF-Α IL-6 diabetic nephropathy Tangshenan hs-CRP TNF-α IL-6
  • 相关文献

参考文献9

  • 1中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58.
  • 2Friedman A N, Hunsicker L G, Selhub J, et al. Clinical and nuitritional correlates of creactive protein in type 2 diabetic nephropathy [ J ]. Atheroselerosls, 2004, 172:121.
  • 3HU F B, MEIGS J B, LIT Y, et al. Inflammatory markers and risk of developing type 2 diabetes in women [ J ]. Diabetes ,2004,53 ( 3 ) :693.
  • 4吴慧芳.2型糖尿病肾病患者超敏C反应蛋白的测定及分析[J].实用全科医学,2008,6(6):594-595. 被引量:11
  • 5Navarro J F, Mora C, G6mez M. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factoralpha and interleukin-6 in type 2 diabetic patients [ J ]. Nephrol Dialy Transplant ,2008,23 ( 3 ) :919.
  • 6Mora C, Navarro J F. Inflammation and diabetic nephropathy [ J ]. Curt Diab Rep,2006,6 (6) 463.
  • 7Dalla Vestra M, Mussap M, Gallina P, et al. Acutephase markers of inflanmmtion and glomerular structure in patients with type 2 diabetes [ J ]. J Am Sac Nephrol, 2005,16( Suppl 1 ) :78.
  • 8王芬,何华亮,江南,贾淑明,刘铜华.糖耐康对自发性2型糖尿病KKAy小鼠胰岛素信号转导的影响[J].中国实验方剂学杂志,2008,14(1):46-49. 被引量:21
  • 9成细华,喻嵘,明霞,伍参荣,谢华庚.左归降糖益肾方对高脂饮食2型糖尿病MKR小鼠糖脂代谢及炎症反应的影响[J].中国实验方剂学杂志,2010,16(12):98-101. 被引量:17

二级参考文献26

共引文献1298

同被引文献288

引证文献25

二级引证文献222

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部